ÇEVRESEL ETKENLERİN GENLER ÜZERİNE ETKİSİ VE GENETİK ANALİZ YÖNTEMLERİ Feriha BAŞOĞLU, Ayşe Emel ÖNAL İst Tıp Fak Derg 2009;72:108-111 Fiziksel ve kimyasal çevresel kirleticilerin insan sağlığı üzerine olan olumsuz etkileri bilinmektedir. Bu olumsuz…
Büyüme Hormonu Eksikliği Ömer Tarım, Halil Sağlam Güncel Pediatri 2010; 8: 36-8 Büyüme hormonu eksikliği (BHE) tedavi edilebilir büyüme gerilikleri içinde en yüz güldürücü olandır. Kalıtsal ve edinsel nedenlere bağlı olabilir. İzole ve…
Clinically relevant diagnostic research in primary care: the example of B-type natriuretic peptides in the detection of heart failure Johannes C Kelder, Frans H Rutten and Arno W Hoes Family Practice 2009 26(1):69-74…
ERİTROSİT SEDİMENTASYON HIZI Doç. Dr. Sevgi Kalayoğlu Beşışık Eritrosit sedimentasyon hızı (ESH) akut faz yanıtını değerlendirmede kullanılan testlerden biridir. Akut faz reaksiyonu bir uyaran varlığında yanıt veren hücrelerden (polimorf nüveli lökositler, antijen sunan…
A systematic review of the diagnostic accuracy of prostate specific antigen. Harvey P, Basuita A, Endersby D, Curtis B, Iacovidou A, Walker M. BMC Urol. 2009; 9: 14. Conclusion Implications for practice PSA…
Paraoxonases: structure, gene polymorphism & role in coronary artery disease. Gupta N, Gill K, Singh S. Indian J Med Res. 2009 Oct;130(4):361-8. Paraoxonases (PONs) i.e. PON1, PON2, PON3 are basically lactonases. Of these,…
Inflammatory markers and poor outcome after stroke: a prospective cohort study and systematic review of interleukin-6. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow…
Can peripheral leukocytes be used as Alzheimer’s disease biomarkers? Rezai-Zadeh K, Gate D, Szekely CA, Town T. Expert Rev Neurother. 2009 Nov;9(11):1623-33. Alzheimer’s disease (AD) is the leading cause of dementia in elderly…
Use of genetic variation as biomarkers for Alzheimer’s disease. Reitz C, Mayeux R. Ann N Y Acad Sci. 2009 Oct;1180:75-96 Late-onset Alzheimer’s disease (LOAD) is the most common cause of late-onset dementia in…
Renal failure–measuring the glomerular filtration rate. Thomas C, Thomas L. Dtsch Arztebl Int. 2009 Dec;106(51-52):849-54. BACKGROUND: Chronic renal disease is common, and its prevalence is rising. Its main causes are hypertension and diabetes…
YKL-40–an emerging biomarker in cardiovascular disease and . Rathcke CN, Vestergaard H. Cardiovasc Diabetol. 2009 Nov 23;8:61. Several inflammatory cytokines are involved in vascular inflammation resulting in endothelial dysfunction which is the earliest…
HDL as a biomarker, potential therapeutic target, and therapy. Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM Diabetes. 2009 Dec;58(12):2711-7. Emerging evidence suggests that HDL function is not always accurately…